Autolus Therapeutics PLC
(FRA:6A3A)
€
3.22
0.02 (0.63%)
Market Cap: 856.91 Mil
Enterprise Value: 285.19 Mil
PE Ratio: 0
PB Ratio: 1.85
GF Score: 58/100 Autolus Therapeutics PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020 / 06:45PM GMT
Release Date Price:
€11.6
(-0.85%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Great. Welcome, everyone. Let's go ahead and get started. My name is Vikram Purohit. I am one of the research analysts with the Morgan Stanley biotech team, and I have on the line with me Christian Itin with Autolus Therapeutics. Christian, welcome. Thank you for joining us.
Christian Martin Itin
Autolus Therapeutics plc - Chairman & CEO
Thanks for having us.
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Sure. And before we get into our conversation, I just need to read a brief disclosure statement. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot